2011

The number of life sciences venture deals was down in the third quarter and first-time funding was down as well. Read more about the reasons behind the numbers.

How will medtech and biotech companies be affected by the recently approved Leahy-Smith America Invents Act? Read more for five things these companies need to know about the modernized patent laws.

Although progress has been made toward creating an artificial pancreas, there is still a long way to go. Read more about the work being done on this medical device.

With medical device companies becoming increasingly frustrated with the U.S. Food and Drug Administration, many American companies are looking to Europe to get approval there first. Here are some tips to consider before pursuing the CE Mark.

Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup health IT companies.

Should the U.S. Food and Drug Administration protect the public or drive innovation? One industry leader gives us his take on the future of the FDA.

Medical foundations play a role in helping medicine advance through their philanthropy, but sometimes even the most well-intentioned of them can lose their way. Read more about how these foundations can stay focused on their goals.

In biotech research, the gathering and analysis of data takes a great deal of time. With portable legal consent, Sage Bionetworks aims to reduce data collection time for researchers so they can make their discoveries earlier.

Biotech companies that work with healthcare payers can get a better sense of the kinds of innovations that are most in demand. Read more about how working with payers can give innovators an edge.

Panelists at the Partnering for Cures conference agreed that straightening out the economy here and abroad would go a long way toward making research dollars available to advance biomedical research. However, until economic conditions improve, it's hard to say how biomedical startups will fare.